Laronde
Bradley D. Laronde, Pennellville, NY US
Patent application number | Description | Published |
---|---|---|
20130173243 | Virtual Mass Emulator - The present invention is directed to a system and method for emulating smart grid devices in a smart grid for demand-response program analysis and optimization. Smart grid devices may be emulated in a virtual environment on a server, and can also be emulated individually on smart grid devices themselves. Demand-response programs can be simulated in a virtual environment with virtual emulated smart grid devices, or they can be simulated in a hybrid real-virtual environment with both real smart grid devices and virtual emulated smart grid devices. Demand-response programs can be simulated serially or in parallel. Additionally, such hybrid demand-response program simulations can be enhanced and optimized by including data obtained from the real smart grid devices into the simulation feed-back loop. | 07-04-2013 |
Frank Laronde, Toronto CA
Patent application number | Description | Published |
---|---|---|
20100034862 | COVALENTLY GRAFTED PHARMACEUTICALLY ACTIVE POLYMERS - The invention relates to graftable polymers comprising biologically active agents and the use of such polymers in the manufacture of shaped articles, such as implantable medical devices and catheters. The graftable polymers are covalently grafted to a surface via one or more grafting moieties incorporated into the pharmaceutically-active graftable polymer. The coated articles of the invention can further comprise tie-coats, and the ratio of polymer:tie coat can be used to adjust the rate of drug elution. | 02-11-2010 |
20100041771 | Bioreponsive Polymers - The invention features biodegradable polymers for the delivery of biologically active agents. The polymers include at least one biologically active agent covalently attached via a polyamide linker susceptible to selective hydrolysis by peptidase enzymes. Hydrolysis of the polyamide linker releases the biologically active agent in vivo. | 02-18-2010 |
20100062974 | COMBINATION THERAPY FOR THE TREATMENT OF BACTERIAL INFECTIONS - The invention features a method for treating a subject diagnosed with, or at risk of developing, a bacterial infection by administering to the subject a combination of biologically active agents. | 03-11-2010 |
Mark Laronde, Breslau CA
Patent application number | Description | Published |
---|---|---|
20140075863 | ADJUSTABLE POCKET DOOR FRAME - A pocket door frame includes a slat having a first end and a second end. The slat is adjustable in length. The pocket door frame includes a spine member attached to the first end of the slat and a jamb member attached to the second opposite end of the slat. A method is provided for installing a pocket door frame. The method includes adjusting the length of a slat having a first end attached to a spine member and a second end attached to a jamb member. | 03-20-2014 |
Sarah Laronde, Hamilton CA
Patent application number | Description | Published |
---|---|---|
20120252697 | TRANSFORMED HUMAN PLURIPOTENT STEM CELLS AND ASSOCIATED METHODS - The present disclosure provides transformed human pluripotent stem cell (t-hPSC). t-hPSCs are not dependent on Oct4 for renewal and survival, however exhibit a sensitivity to reduced levels of the transcription factor Nanog. Also provided are methods of culturing cells for use in a cell-based screening assay comprising placing one or more transformed human pluripotent stem cells into a receptacle and culturing said stem cells in the receptacle to form a monolayer of stem cells without cell overlap. Methods of screening compounds using t-hPSCs are also described. | 10-04-2012 |
20150038371 | TRANSFORMED HUMAN PLURIPOTENT STEM CELLS AND ASSOCIATED METHODS - The present disclosure provides transformed human pluripotent stem cell (t-hPSC). t-hPSCs are not dependent on Oct4 for renewal and survival, however exhibit a sensitivity to reduced levels of the transcription factor Nanog. Also provided are methods of culturing cells for use in a cell-based screening assay comprising placing one or more transformed human pluripotent stem cells into a receptacle and culturing said stem cells in the receptacle to form a monolayer of stem cells without cell overlap. Methods of screening compounds using t-hPSCs are also described. | 02-05-2015 |